While hACE2 mice survived infection at a SARS-CoV-2 dose that was lethal to most K18-hACE2 mice, it remains possible that hACE2 mice may exhibit mortality with higher doses, and thus it will be important to carry out additional dose-response curves in the future. This evidence concerns the gene KRT18 and infection.